Blog
RSS FeedPosted by Michael Wonder on 09 Dec 2019
Proposals for funding in the blood, alimentary and immunosuppressant therapy areas
9 December 2019 - PHARMAC is seeking feedback on proposals to widen funded access to medicines in the blood, alimentary ...
Posted by Michael Wonder on 05 Dec 2019
How China’s new drug buying program is causing pain
6 December 2019 - China is overhauling its health-care system with the aim of providing broader access to quality drugs for ...
Posted by Michael Wonder on 05 Dec 2019
Information on efficient funding of chemotherapy reviewed
5 December 2019 - The publicly available information for the Efficient Funding of Chemotherapy has been revised and is now available. ...
Posted by Michael Wonder on 04 Dec 2019
B.C. wants federal health funding lift before national pharmacare program
3 December 2019 - B.C. wants more money from Ottawa for health care before a national pharmacare program is created, ...
Posted by Michael Wonder on 03 Dec 2019
Patient advocacy group demands doubling of PHARMAC budget to fund life-saving treatments
3 December 2019 - A group of patient advocates are calling for PHARMAC's billion-dollar budget to be doubled so it ...
Posted by Michael Wonder on 02 Dec 2019
China updates drug reimbursement list, agrees price cuts
2 December 2019 - Drugs added include AbbVie's Humira and Roche's Perjeta. ...
Posted by Michael Wonder on 27 Nov 2019
Changes to wastage funding
27 November 2019 - PHARMAC is seeking feedback on a proposal relating to how it funds discarded medicines (“wastage”) in ...
Posted by Michael Wonder on 18 Nov 2019
Funding orphan medicinal products beyond price: sustaining an ecosystem
18 November 2019 - Following a similar legislation in the USA, the EU passed a legislation in 1999 to incentivise ...
Posted by Michael Wonder on 12 Nov 2019
Rare Disease Fund now covers Pompe disease, a rare inherited neuromuscular disorder
3 November 2019 - The Rare Disease Fund now covers Singaporeans with Pompe disease - a rare inherited neuromuscular disorder ...
Posted by Michael Wonder on 03 Nov 2019
Hundreds of Kiwis battling leukaemia given hope with funding of new drug
4 November 2019 - Hundreds of Kiwis battling leukaemia cancer have been given hope, with PHARMAC today announcing funding for ...
Posted by Michael Wonder on 31 Oct 2019
Parallel distributed or parallel imported Maviret and Viekirax remain in high cost protection
28 October 2019 - TLV has reconsidered the subsidy for parallel distributed or parallel imported Maviret and Viekirax and decided ...
Posted by Michael Wonder on 31 Oct 2019
Response to media on new MBS items for eating disorders
30 October 2019 - In response to this morning’s media the Department of Health advises that the new items that will ...
Posted by Michael Wonder on 31 Oct 2019
Proposal to widen access to rituximab and change the funded brand for all funded indications excluding rheumatoid arthritis
31 October 2019 - PHARMAC is seeking feedback on a proposal to make changes to the funded brand of rituximab, ...
Posted by Michael Wonder on 29 Oct 2019
Breast cancer MRI added to Medicare
29 October 2019 - Women with or suspected of having breast cancer will be able to claim Medicare benefits for magnetic ...
Posted by Michael Wonder on 29 Oct 2019
Battle for life-saving drugs now harder as PHARMAC absorbs $5m rare disorders fund
29 October 2019 - A $5 million fund set up by PHARMAC in 2014 to address rare disorders no longer ...